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ABSTRACT
Background: Dobutamine is commonly used for clinical management of heart 
failure and its pharmacological effects have long been investigated as inotropics 
via β–receptor activation. However, there is no electrophysiological evidence if 
dobutamine contributes inotropic action due at least partially to the reverse mode of 
Na+-Ca2+ exchanger (NCX) activation.
Methods: Action potential (AP), voltage-gated Na+ (INa), Ca2+ (ICa), and K+  
(Ito and IK1) currents were observed using whole-cell patch technique before and 
after dobutamine in ventricular cardiomyocytes isolated from adult mouse hearts. 
Another sets of observation were also performed with Kb-r7943 or in the solution 
without [Ca2+]o.
Results: Dobutamine (0.1–1.0 μM) significantly enhanced the AP depolarization 
with prolongation of AP duration (APD) in a concentration-dependent fashion. The 
density of INawas also increased concentration-dependently without alternation 
of voltage-dependent steady-status of activation and inactivation, reactivation as 
well. Whereas, the activities for ICa, Ito, and IK1 were not changed by dobutamine. 
Intriguingly, the dobutamine-mediated changes in AP repolarization were abolished 
by 3 μM Kb-r7943 pretreatment or by simply removing [Ca2+]o without affecting 
accelerated depolarization. Additionally, the ratio of APD50/APD90 was not significantly 
altered in the presence of dobutamine, implying that effective refractory period was 
remain unchanged.
Conclusion: This novel finding provides evidence that dobutamine upregulates of 
voltage-gated Na+ channel function and Na+ influx-induced activation of the reverse 
mode of NCX, suggesting that dobutamine may not only accelerate ventricular 
contraction via fast depolarization but also cause Ca2+ influx, which contributes its 
positive inotropic effect synergistically with β-receptor activation without increasing 
the arrhythmogenetic risk.
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INTRODUCTION
Dobutamine is a sympathomimetic drug that has 
long been used in the treatment of heart failure [1] and 
cardiogenic shock [2] on the basis of its positive inotropic 
action. Its primary mechanism is direct stimulation of 
β-receptors of the sympathetic nervous system coupled with 
intracellular Ca2+ mobilization through G-protein-couple 
receptor and cyclic adenosine-monphosphate (cAMP) 
pathway. However, if other potential mechanism except for 
β-receptor stimulation involved in dobutamine-mediated 
intracellular Ca2+ mobilization is not fully understand so 
far. Recent finding has shown that Na+ influx during the 
early phase of action potential (AP) induces an intracellular 
Ca2+ increase through activation of the reverse mode of 
Na+-Ca2+ exchanger (NCX) [3–5] and there is no such 
report in the literatures if dobutamine share the similar 
mechanisms. Therefore, this study was designed to answer 
the following questions regarding the electrophysiological 
profiles of dobutamine: [1] if voltage-gated Na+ channel 
is activated; [2] if Na+ influx induces the Ca2+ entry via 
the reverse mode of NCX in an extracellular-dependent 
manner; and [3] the relation between [1] and [2]. To 
experimentally verify these questions, both AP and 
voltage-gated ion channel currents (I
Na
, ICa, IK1, and Ito) 
were investigated on ventricular cardiomyocytes isolated 
from adult mouse heart, respectively, using whole-cell 
patch technique [6, 7] before and after administration 
of dobutamine. Additionally, separate sets of current-
clamp observations were also performed by pretreatment 
of cardiomyocytes with Kb-r7943, selective NCX 
blocker, with normal Tyrode’s solution or calcium free 
Tyrode’s solution to verify the involvement of NCX and 
Ca2+-dependency. This observation provides a solid 
evidence to suggest that dobutamine mediates Na+ influx 
through voltage-gated Na+ channel during AP depolarization 
and consequently induces an extracellular Ca2+-dependent 
Ca2+ influx through the reverse mode of NCX in ventricular 
cardiomyocyte of adult mouse heart.
MATERIALS AND METHODS
Animals
For consistency, only 8 week-old young adult male 
mice were used for experiments unless otherwise indicated. 
All animal protocols were approved by Harbin Medical 
University or Indiana University School of Medicine 
Institutional Animal Care and Research Advisory Committee.
Chemical agents
Dobutamine and Kb-r7943 [8], a selective blocker 
for the reverse mode of Na+-Ca2+ exchanger (NCX), were 
ordered directly from Sigma-Aldaich. Chemical agents 
for cell culture, enzymatic isolation of cardiomyocyte, 
and recording solutions were purchased from the regular 
commercial sources.
Ventricular cardiomyocyte isolation
Adult mouse single ventricular cardiomyocytes 
were isolated using Langendorff-perfused mouse 
hearts and standard enzymatic techniques as previously 
reported with minor modifications [9]. Briefly, mice 
were heparinized and sacrificed by cervical dislocation. 
The hearts were rapidly removed and retrogradely 
perfused through the aorta using a modified Langendorff 
apparatus. The preparation was perfused with calcium free 
Tyrode’s solution (in mM: NaCl 126, KCl 5.4, HEPES 10, 
NaH2PO4 0.33, MgCl2 1.0, taurine 10, glucose 10, and pH 
adjusted to 7.4 with 1.0 N NaOH) for 5 min, and then 
switched to digestive solution (calcium free Tyrode’s 
solution containing Collagenase type-II 0.4 mg/ml, 
protease 0.02 mg/ml and BSA 1.0 mg/ml). Left atria and 
ventricular tissue were collected and titrated gently in 
calcium free Tyrode’s solution containing 0.5% BSA to 
obtain single cells. All solutions were gassed with 95% 
oxygen and 5% carbon dioxide. Single rod-shaped and 
Ca2+ tolerant cells with clear cross-striations (Figure 1A) 
were used for electrophysiological investigation.
 Electrophysiology
Both current- (AP) and voltage-clamp recordings 
(I
Na
, ICa, Ik1, and Ito) were conducted using standard 
whole-cell patch-clamp techniques [10, 11] with an 
Axopatch 700B amplifier (Axon Instruments). Briefly, The 
recording electrodes (Borosilicate glass, Sutter) were pulled 
(P-97, Sutter Instruments) and polished (F-83, Narishige) 
down to 1.2 – 1.8 MΩ when filled with pipette solution. 
After formation of the gigaohm-seal, the capacitance was 
electronically compensated and the cell membrane under 
the pipette tip was then ruptured by a brief increase in 
suction, forming the whole-cell recording configuration. 
After 2–5 min period for intracellular dialysis, the Tyrode 
solution was changed by bath perfusion of extracellular 
recording solution designed for I
Na
, ICa, Ik1, and Ito 
recordings, respectively. All cells were recorded at room 
temperature (22 – 23°C). Current amplitude data of each 
cell were normalized to its cell capacitance (current density, 
pA/pF). Current-voltage relationship (I-V curve) was 
presented by the currents normalized by the peak currents. 
Voltage-dependent activation and steady-state inactivation 
profiles were calculated by Boltzmann fitting function.
Recording solution
For AP, normal Tyrode’s solution was used (in mM): 
NaCl 125, KCl 4.5, NaH2PO4 1.8, NaHCO3 24, CaCl2 1.8, 
MgCl2 0.5, and Glucose 5.5 and with pH adjusted to 7.40 
with 1.0 N NaOH; and the pipette solution contained 
(in mM): K-glutamate 130; KCl 15; NaCl 5.0; Mg-ATP 5; 
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MgCl2 1.0; EGTA 5.0; CaCl2 1.0; HEPES 10, and pH 
adjusted to 7.2 with KOH.
For I
Na
, pipette solution was (in mM): CsOH 125; 
Aspartic acid 35; tetraethylammonium chloride 30; 
HEPES 11; Mg-ATP 5.0; EGTA 10; phosphocreatine 3.6, 
pH adjusted to 7.30 with 1.0 N CsOH, and recording 
solution contained (in mM): NaCl 50; MgCl2-6H2O 1.2; 
CaCl2 1.8; Tetraethylammonium chloride 125; CsCl 5.0; 
HEPES 20; Glucose 11; 4-AP 3.0; MnCl2 2.0; and pH 
adjusted to 7.30 with 1.0 N CsOH.
For ICa, pipette solution was prepared (in mM): 
CsCI 20, MgCl2-6H2O 1, Mg-ATP 5, EGTA 10, 
CSOH 110, asparate 110, HEPES 10, and pH adjusted to 
7.2 using CsOH, and recording solution contained (in mM): 
Tris-Cl 136, CsCl 5.4, CaCl2 2.0, MgCl2-6H2O 1.0, 
HEPES 10, glucose 5.0, and pH adjusted to 7.4 using Tris.
For IK, pipette solution contained (in mM): 
K-glutamate 130; KCl 15; NaCl 5.0; Mg-ATP 5.0; 
MgCl2 1.0; EGTA 5.0; CaCl2 1.0; HEPES 10, and pH 
adjusted to 7.2 with 1.0 N KOH, and recording solution 
contained (in mM): NaCl 138, KCl 5.4, CaCl2 1.8, MgCl2 
1.0, CdCl2 0.3, Nifedipine 0.02, HEPES 10, 10 glucose, 
and pH adjusted to 7.4 with 1.0 N NaOH.
Statistical analysis
Data were collected using Clampfit and analyzed 
using Origin and Excel. The EC
50
 was estimated using 
sigmoidal fitting function from the dose-response curve. 
Continuous variables are presented as mean ± SD. 
Student’s t-tests were used to compare the means between 
groups. P ≤ 0.05 was considered statistically significant.
RESULTS
APs, I
Na
, IK1, Ito, and ICa before and after treatments 
with dobutamine were investigated, respectively, in 
ventricular cardiomyocytes and only those completely 
recordings with control and test were included in the 
pooled data for further analysis. The number of observation 
in each group was collected from at least 3 mouse heart.
Changes in AP discharge profiles in the presence 
of dobutamine
In isolated ventricular cardiomyocyte (Figure 1A, 
n = 12), AP discharge parameters were altered by 
Figure 1: Concentration-dependent effects of dobutamine on action potential (AP) discharge character in ventricular 
cardiomyocyte isolated from adult mouse heart. AP was elicited from the resting membrane potential by a brief pulse with 2 ms 
duration using current-clamp mode. A. representative image of ventricular cardiomyocyte with recording pipette collected during recording 
under 40× light microscope; B. and C. representative AP and derivative over the membrane potential before and after 1 μM dobutamine, 
respectively; D. superimposition of APs recorded in the absence and presence of 0.1 – 1 μM dobutamine.
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dobutamine in a concentration-dependent manner 
(Figure 1B–1D, Table 1), manifested as slight but 
significant increase in the resting membrane potential 
(RMP) and AP firing threshold (APFT) toward the 
hyperpolarized direction, also increase in the rate of 
depolarization revealed by maximal upstroke velocity 
(UV
MAX
) measured from the derivative current changes 
over the membrane potential without altering the peak 
of APs. Whereas, AP durations (APD
50
 and APD
90
) were 
prolonged with decrease in the maximal downstroke 
velocity (DV
MAX
). These results suggest that multiple ion 
channel mechanisms may be involved in the changes in AP 
discharge profiles. Additionally, the EC
50
 of dobutamine for 
UV
MAX
 and APD
50
, a parameter to represent depolarization 
and repolarization function, were estimated differently at 
0.151 μM and 0.248 μM, respectively, indicating separate 
mechanisms being involved in the corresponding changes. 
Intriguingly, the ratio of APD
50
/APD
90
 at all concentrations 
are nearly one (0.98~0.99), implying that the absolute 
effective refractory period (ERP) was lengthened in 
parallel along with APD prolongation.
Effect of dobutamine on voltage-gated Na+ 
channel activity
Upon the effect of dobutamine on the parameters of 
AP depolarization including RMP, APFT, and UV
MAX
, the 
changes in current density and/or the voltage-dependent 
property of Na+ channel in the presence of dobutamine 
are highly expected. In this regard, I
Na
 was collected 
(Figure 2A & 2B) and averaged data showed that the 
I
Na
 density was enhanced concentration-dependently 
without shifting in the peak of I
Na
 (Figure 2A, inset), 
however, voltage-dependent steady-status activation and 
inactivation, as well as reactivation profiles were not 
markedly changed (Figure 2C–2D) by dobutamine. The 
EC
50
 of dobutamine for the density of I
Na
 was estimated 
at 0.143 μM, which is correspondent well with the EC
50
 
for UV
MAX
 of AP simply because the I
Na
 is the current 
underlying the AP depolarization.
Contribution of ICa on dobutamine-mediated 
APD prolongation
According to lengthened APD and slowed 
repolarization in the presence of dobutamine, the 
modulation of voltage-gated Ca2+ channel would be one 
of potential mechanism. To test this hypothesis, ICa was 
recorded from ventricular cardiomyocytes isolated from 
adult mouse heart before and after dobutamine and the 
results showed that neither the current density nor I-V 
relationship (Figure 3) were changed by dobutamine, 
implying that voltage-gated K+ channels (Ito and IK1) would 
be the next target to elucidate.
Involvement of IK1 and Ito in dobutamine-
mediated slow repolarization
Voltage-gate K+ channels, such as IK1 and Ito, are 
dominate currents for AP repolarization in mouse, which 
play an opposite role against ICa, and the down-regulation 
of IK1 and Ito would also cause increased APD and slowed 
repolarization. Surprisingly, the current density and 
voltage-dependent property (Figure 4 & 5) for both IK1 
Table 1: Effects of dobutamine (0.1, 0.3, and 1 μM) on discharge profiles of AP recorded from 
ventricular cardiomyocytes isolated from adult mouse heart. Averaged data were presented as mean 
± SD, n = 12 myocytes from at least 4 mice. *P < 0.05 and **P < 0.01 vs control
Parameter Control 0.1 μM Dob 0.3 μM Dob 1 μM Dob Washout
RMP -79.4 ± 3.88 -81.2 ± 3.47 -83.6 ± 3.12* -84.8 ± 3.44** -80.6 ± 3.73
APFT -57.1 ± 4.13 -58.8 ± 3.42 -61.3 ± 4.05* -63.6 ± 4.66** -58.8 ± 3.99
PeakAP 56.1 ± 5.11 56.9 ± 4.23 57.8 ± 3.41 58.8 ± 3.18 58.2 ± 4.15
APD50 3.87 ± 0.67 4.45 ± 0.81 5.51 ± 0.76* 6.14 ± 0.64** 4.33 ± 0.59
% of APD50 100% 114.98% 142.38% 158.66% 111.89
APD90 11.1 ± 2.04 13.0 ± 2.67 15.9 ± 3.82* 17.7 ± 4.37** 12.6 ± 4.02
% of APD90 100% 117.11 143.24% 159.46% 113.51%
UVMAX 193 ± 20 237 ± 14* 260 ± 17** 266 ± 27** 208 ± 15
DVMAX -28.3 ± 4.24 -31.3 ± 4.36 -37.9 ± 3.24* -46.4 ± 3.88** -33.6 ± 3.78
Note: RMP: resting membrane potential (mV); APFT: AP firing threshold (mV); PeakAP: the peak of AP (mV); APD50: AP 
duration measured at 50% of the height (ms); APD90: AP duration measured at 90% of the height (ms); UVMAX: the maximal 
upstroke velocity of depolarization (mV/ms); DVMAX: the maximal downstroke velocity of repolarization (mV/ms).
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Figure 2: Dobutamine-mediated increase in the current density of voltage-gated Na+ channel (INa) without changing 
the voltage-dependent properties of activation and inactivation in ventricular cardiomyocyte isolated from adult 
mouse heart. For activation of I
Na
 recording in voltage-clamp mode, the cell was hold at −100 mV and 400 ms depolarization current 
pulse was stepped from -90 mV to +30 mV with 5 mV increments and 1-s interval between steps, for inactivation protocol, the cell 
was hold at -100 mV with double pulse protocol, before the test pulse 1-s conditioning pre-pulse was stepped from -120 mV to -30 mV 
5 mV increment and followed by 20 ms test pulse at 2 ms immediately after the prepulse and stepped to -30 mV with 3-s step interval, 
for reactivation protocol, . The current density (pA) was normalized by whole-cell capacitance (pF) and voltage-dependent activation 
and inactivation curve were fitted by Boltzmann function (normalized conductance). All representative traces shown in this figure are 
from the same patch recordings. A. and B. voltage-dependent activation of I
Na
 before and after 1.0 μM dobutamine. inset: the current-
voltage relationship (I-V curve). Scale bars in B also apply for A; C. and D. voltage dependent inactivation and reactivation, respectively; 
E. voltage-dependent activation and inactivation curves; and F. voltage-dependent reactivation curves. Voltage-dependent property was 
fitted using Boltzmann equation and averaged data were presented as mean ± SD, n = 8 recordings from at least 3 mouse heart.
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Figure 3: Effects of dobutamine on voltage-gated Ca2+ channel (ICa) recorded in ventricular cardiomyocyte isolated 
from adult mouse heart. For ICa recording, the cell was hold at -80 mV and 400 ms depolarization current pulse was stepped from 
−60 mV to + 60 mV with 5 mV increment and 1-s step interval. A. and B. representative recordings of ICa before and after 1 μM dobutamine, 
respectively; C. current-voltage relationship (I-V curve). averaged data were presented as mean ± SD, n = 6 recordings from 3 mouse heart.
Figure 4: Effects of dobutamine on voltage-gated K+ channel (Ito) recorded in ventricular cardiomyocyte isolated from 
adult mouse heart. For Ito, the cell was hold at −40 mV and 600 ms depolarization current pulse was stepped from −40 mV to + 50 mV 
with 10 mV increment and 1-s step interval. A. and B. representative recordings of Ito before and after 1 μM dobutamine, respectively;  
C. current-voltage relationship (I-V curve). averaged data were presented as mean ± SD.
Figure 5: Effects of dobutamine on voltage-gated K+ channel (IK1) recorded in ventricular cardiomyocyte isolated from 
adult mouse heart. For IK1, the cell was hold at −40 mV and 300 ms depolarization current pulse was stepped from −120 mV to + 50 
mV with 10 mV increment and 1-s step interval. A. and B. representative recordings of IK1 before and after 1 μM dobutamine, respectively;  
C. current-voltage relationship (I-V curve). averaged data were presented as mean ± SD.
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and Ito were not modified by the highest concentration (1 
μM) of dobutamine.
Extracellular-dependency of dobutamine-
mediated changes in AP repolarization
Even though, IK1 and Ito, and ICa as well were not 
involved in dobutamine-mediated AP repolarization 
changes, intracellular Ca2+ mobilization through other 
transmembrane mechanism rather than voltage-gated Ca2+ 
is then expected. To verify if the extracellular Ca2+ influx 
occurs during the AP repolarization, removing extracellular 
Ca2+ instead of using Mg2+ would be the easiest way. In 
another set of experiment, the effect of dobutamine on AP 
was repeated in the normal recording solution with 2 mM 
Ca2+. Interestingly, the similar results induced by 1 μM 
dobutamine were disappeared at ~2 min after complete bath 
perfusion (~1 ml/min) with 0 mM Ca2+ recording solution 
(Figure 6A & 6B), strongly indicating the Ca2+-dependency 
of dobutamine-mediated changes in AP repolarization.
Effect of Kb-r7943 on dobutamine-mediated 
changes in AP repolarization
Recent observation provides an evidence showing 
the potential connection between Nav1.5 and Na+-Ca2+ 
exchanger (NCX) [3, 4], which is a possible clue for 
an explanation regarding the effects of dobutamine 
AP discharge profiles. To test this hypothesis in our 
experimental condition, the APs were elicited in current-
clamp configuration in ventricular cardiomyocytes. The 
results showed that the AP repolarization changes induced 
by 1.0 μM dobutamine were completely blocked by the 
pretreatment of cardiomyocyte with 3 μM Kb-r7943 
(Figure 6C & 6D), a selective blocker for NCX, without 
affecting increased AP depolarization (UV
MAX
).
Figure 6: Reverse mode of Na+-Ca2+ exchanger (NCX)- and extracellular Ca2+ ([Ca2+]o)-dependent effects of dobutamine 
on AP discharge profiles. A. and B. APs and derivatives before and after 1 μM dobutamine and dobutamine plus 3 μM Kb-r7943;  
C. and D. APs and derivatives before and after 1 μM dobutamine with 2 mM [Ca2+]o and dobutamine with 0 mM [Ca2+]o. Scale bars shown 
in C and D are also apply for A and B, respectively.
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DISCUSSION
Dobutamine is a sympathomimetics and activates 
β-adrenergic receptors (β1 and β2 mediating cardiac and 
vascular effects, respectively) as an inodilator [12] and 
can be used in cases of congestive heart failure to increase 
cardiac output and positive inotropic support in the short-
term treatment of patients with cardiac decompensation due 
to depressed contractility. Even though the clear beneficial 
effect of dobutamine the appropriate role of intravenous 
inodilator therapy in the management of congestive heart 
failure has long been a subject of controversy and limitation, 
mainly because of the side effects such as increased heart 
rate and O2 consumption via β-receptor activation [13], and 
direct vascular effect and baroreflex feed-back regulation 
[14]. So, further investigation is definitely necessary 
to elucidate the exist electrophysiological mechanism 
underlying the therapeutic effect of dobutamine, which 
may in turn benefit for the future clinical application and 
pharmacological convention of dobutamine.
The major finding of this observation has 
demonstrated, for the first time by our knowledge, that the 
extracellular Ca2+-dependent Na+-induced Ca2+ influx is 
confirmed in ventricular cardiomyocyte in the presence of 
dobutamine in a concentration-dependent manner through 
voltage-gated Na+ channel (Nav1.5) activation during AP 
depolarization and consequently activation of the reverse 
mode of NCX and the intracellular Ca2+ mobilization 
during prolonged AP repolarization, which may be a novel 
mechanism of positive inotropic action of dobutamine 
except for the known β1-receptor activation and G-protein 
coupled cAMP pathway.
Clearly, dobutamine accelerates the AP 
depolarization with shifting of RMP and AP firing 
threshold toward the hyperpolarized direction and this 
observation is supported by the notion of increased I
Na
 
density presumably due to the enhanced availability 
of voltage-gated Na+ channel at given relatively lower 
potential upon the inactivation profiles. In this particular 
case, a relatively less energy would be required to charge 
the membrane and therefore causing the reduction of AP 
firing threshold without alternation of voltage-dependent 
activation and inactivation properties. However, 
dobutamine-induced RMP hyperpolarization might 
be explained by the dobutamine-induced myocardial 
K+ uptake by β1-adrenoreceptor and adenylate cyclase 
activation [13] and the Nernst Equation.
Not surprisingly, the outward K+ currents are the 
first to respond to a depolarizing event on account of the 
hyperpolarized activation profile and fast activation time 
constant for these currents. Moreover, as the membrane 
potential enters into a phase of rapid depolarization there 
is a marked recruitment of transient and Ca2+-activated 
K+ currents, which are primary outward K+ currents 
responsible for the terminating the AP upstroke and 
initiating a reversal in the trajectory of the membrane 
potential upon a Hodgkin-Huxley model [15–17]. In other 
words, the more faster depolarization occurs, the more K+ 
channels would be recruited during the repolarization and 
sequentially causing a shorter AP duration. Interestingly, 
although dobutamine caused a fast depolarization the 
larger K+ currents recruitment, especially the transient 
(Ito), were not observed from the voltage-clamp records, 
suggesting other ion channel mechanism being involved in 
this event and the most suspicious one is ICa, unfortunately, 
this hypothesis was also not confirmed under the current 
experimental condition.
Recently, several reports indicate the potential 
role of the reverse mode of NCX in an intracellular 
Ca2+ mobilization [3, 4], which could be cytoplasmic 
Na+-dependent [5] and activated during the AP 
depolarization [18] in mouse and human. In this regard, 
by preincubation of ventricular cardiomyocytes with 
Kb-r7943, a selective NCX blocker, dobutamine-mediated 
changes in repolarization were disappeared without 
altering the depolarization, which was also confirmed by 
simply removing the extracellular Ca2+. Even though the 
extracellular Ca2+ was not added in our recording solution, 
the concentration for extracellular Ca2+ came from the 
distilled water and chemicals would be close to 1 μM 
[19], which may be enough to maintain the cell function 
and signaling cascades. These data strongly suggest that 
dobutamine causes extracellular Ca2+-dependently Na+-
induced Ca2+ influx through the reverse mode of NCX.
Collectively, in the presence of dobutamine, 
unchanged ratio of APD
50
/APD
90
 may not increases the 
risk for arrhythmogenesis because the effective refractory 
period remains no change along with the similar extend 
prolongation of both APD
50
 and APD
90
. Meanwhile, the 
prolonged AP duration would limit heart rate increased 
by β1-receptor stimulation, fast depolarization would 
produce a fast ventricular contraction and offer a relative 
longer period of time for cardiac diastolation. KB-R7943 
is a potent, selective inhibitor of the reverse mode of the 
Na+/Ca2+ exchanger, but its modulatory effects on other 
receptor systems, such as the inhibition of Kb-r7943 
on nicotinic receptor [20] and N-methyl-D-aspartate 
receptor [8] in nervous system, can not be excluded 
in cardiomyocytes under the current investigation. It 
would be necessary to verify the effect of Kb-r7943 on 
β-adrenoreceptor in the future experiment although it has 
not been documented so far.
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